Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 164 NOK 1.55% Market Closed
Market Cap: 3B NOK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MEDI stock under the Base Case scenario is 220.62 NOK. Compared to the current market price of 164 NOK, Medistim ASA is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDI Relative Value
Base Case
220.62 NOK
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.3
P/S
P/S
Price to Sales
5.3
vs History
95
vs Industry
21
Median 3Y
7.4
Median 5Y
9.5
Industry
2.2
Forward
4.9
More Details
28.9
P/E
P/E
Price to Earnings
28.9
vs History
95
vs Industry
16
Median 3Y
35.5
Median 5Y
44
Industry
21.9
Forward
28
More Details
21
P/OCF
P/OCF
Price to OCF
21
vs History
96
vs Industry
13
Median 3Y
34.5
Median 5Y
36.8
Industry
13.5
More Details
27.5
P/FCFE
P/FCFE
Price to FCFE
27.5
vs History
87
vs Industry
16
Median 3Y
35.6
Median 5Y
43.4
Industry
19.3
More Details
6.9
P/B
P/B
Price to Book Value
6.9
vs History
96
vs Industry
8
Median 3Y
10.2
Median 5Y
12.7
Industry
2.1
More Details
5.1
EV/S
EV/S
Enterprise Value to Sales
5.1
vs History
90
vs Industry
20
Median 3Y
7.2
Median 5Y
9.2
Industry
2.3
Forward
4.6
More Details
6.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.3
vs History
90
vs Industry
29
Median 3Y
9.1
Median 5Y
11.8
Industry
4.8
More Details
18.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.3
vs History
92
vs Industry
12
Median 3Y
24.4
Median 5Y
33
Industry
11.5
Forward
18.1
More Details
21.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.7
vs History
90
vs Industry
17
Median 3Y
27
Median 5Y
34.3
Industry
15.6
Forward
20.2
More Details
19.9
EV/OCF
EV/OCF
Enterprise Value to OCF
19.9
vs History
92
vs Industry
13
Median 3Y
33.3
Median 5Y
35.7
Industry
13.3
More Details
24.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.1
vs History
84
vs Industry
17
Median 3Y
33.6
Median 5Y
40.1
Industry
17.3
More Details
7.2
EV/IC
EV/IC
Enterprise Value to IC
7.2
vs History
92
vs Industry
9
Median 3Y
12
Median 5Y
13.8
Industry
1.8
More Details

Multiples Across Competitors

MEDI Competitors Multiples
Medistim ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Medistim ASA
OSE:MEDI
3B NOK 5.3 28.9 18.3 21.7
US
Abbott Laboratories
NYSE:ABT
229B USD 5.4 17 22 31.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.3B USD 21.9 76.9 61.4 73.8
US
Boston Scientific Corp
NYSE:BSX
153.9B USD 8.8 75.9 35.7 49.5
US
Stryker Corp
NYSE:SYK
145.8B USD 6.5 48.7 25.2 30.4
IE
Medtronic PLC
NYSE:MDT
107.1B USD 3.2 25.2 13.5 19
DE
Siemens Healthineers AG
XETRA:SHL
53.6B EUR 2.4 27 15.6 22.2
US
Becton Dickinson and Co
NYSE:BDX
49B USD 2.4 27.8 12.5 22.5
US
Edwards Lifesciences Corp
NYSE:EW
44.4B USD 8 10.6 24.3 26.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.9B USD 10.1 43.9 31.1 34.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
266.3B CNY 7.5 23.9 20.9 20.9

See Also

Summary
MEDI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDI stock valuation using valuation multiples.
Wall Street Estimates
MEDI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 252,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.